Aerovate

Aerovate

Developing disease modifying therapies for patients who suffer from pulmonary arterial hypertension.

HQ location
Boston, United States
Launch date
Employees
Market cap
$78.8m
Enterprise value
$633k
Share price
$2.68 AVTE
Authorizing premium user...